HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Search for Related Content Social Bookmarking                What's this?

Executive Summary: Standards of Medical Care in Diabetes—2008

Abbreviations: ABI, ankle-brachial index • ADA, American Diabetes Association • ARB, angiotensis receptor blocker • CBG, capillary blood glucose • CHD, Coronary heart disease • CKD, chronic kidney disease • CVD, cardiovascular disease • DMMP, diabetes medical management plan • DPN, distal symmetric polyneuropathy • DSME, diabetes self-management education • FPG, fasting plasma glucose • GDM, gestational diabetes mellitus • GFR, glomerular filtration rate • IFG, impaired fasting glucose • IGT, impaired glucose tolerance • MNT, medical nutrition therapy • NPDR, proliferative diabetic retinopathy • OGTT, oral glucose tolerance test • PAD, peripheral arterial disease • PDR, proliferative diabetic retinopathy • SMBG, self-monitoring of blood glucose • TSH, thryoid-stimulating hormone

The first 300 words of the full text of this article appear below.

These standards of care are intended to provide clinicians, patients, researchers, payors, and other interested individuals with the components of diabetes care, treatment goals, and tools to evaluate the quality of care. While individual preferences, comorbidities, and other patient factors may require modification of goals, targets that are desirable for most patients with diabetes are provided. These standards are not intended to preclude more extensive evaluation and management of the patient by other specialists as needed.

The recommendations included are screening, diagnostic, and therapeutic actions that are known or believed to favorably affect health outcomes of patients with diabetes. A grading system developed by the American Diabetes Association and modeled after existing methods was utilized to clarify and codify the evidence that forms the basis for the recommendations. The level of evidence that supports each recommendation is listed after each recommendation using the letters A, B, C, or E.

For more detailed information, refer to the full document: "Standards of Medical Care in Diabetes—2008."

TOPIC AREAS AND RECOMMENDATIONS

Diagnosis of Diabetes

• The fasting plasma glucose (FPG) text is the preferred test to diagnose diabetes in children and nonpregnant adults. (E)
  
• Use of the A1C for the diagnosis of diabetes is not recommended at this time. (E)
  

Testing for Pre-diabetes and Diabetes

• Testing to detect pre-diabetes and type 2 diabetes in asymptomatic people should be considered in adults who are overweight or obese (BMI 25 kg/m²) and who have one more more additional risk factors for diabetes. In those without these risk factors, testing should begin at age 45. (B)
  
• If tests are normal, repeat testing should be carried out at least at 3-year intervals. (E)
  
• To test for pre-diabetes or diabetes, either an FPG test or 2-h oral glucose tolerance test (OGTT; 75-g glucose load), or both, is appropriate. (B)
  
• An OGTT may be considered in patients with impaired fasting glucose . . . [Full Text of this Article]

CiteULike

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				G. L. Bakris and M. Berkwits Trials That Matter: The Effect of a Fixed-Dose Combination of an Angiotensin-Converting Enzyme Inhibitor and a Diuretic on the Complications of Type 2 Diabetes Ann Intern Med, March 4, 2008; 148(5): 400 - 401. [Full Text] [PDF]